Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Caffeine citrate 20mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Caffeine citrate 20mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Caffeine citrate 20mg/mL oral solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Caffeine citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Product containing caffeine citrate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Product containing caffeine citrate in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Caffeine citrate 20 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Caffeine citrate |
Inferred relationship |
Some |
|
Caffeine citrate 20 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Caffeine citrate 20 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine citrate 20 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Caffeine citrate |
Inferred relationship |
Some |
1 |